Causal associations between CD40/CD40L and aortic diseases: A mendelian randomization study

Xiao Cui1, Tianming Xuan1, Siyuan Chen2

  • 1Department of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Frontiers in Genetics
|November 28, 2022
PubMed

Insights

This study used Mendelian randomization to investigate the causal link between CD40/CD40L and aortic diseases. Findings suggest CD40 causally reduces the risk of aortic dissection and aneurysm.

Area of Science:

  • Genetics and Cardiovascular Disease Epidemiology
  • Immunology and Aortic Pathologies

Background:

  • Previous studies suggested associations between CD40/CD40L and aortic diseases (AD/AA).
  • Causality of these associations remained unestablished prior to this research.

Purpose of the Study:

  • To assess the causal inference between CD40/CD40L and aortic dissection (AD) and aortic aneurysm (AA).
  • To utilize Mendelian randomization (MR) for robust causal effect estimation.

Main Methods:

  • A two-sample Mendelian randomization (MR) study design was employed.
  • Instrumental variables for CD40 and CD40L were derived from a large European ancestry protein quantitative trait loci dataset.
  • Genome-wide association study summary statistics for AD and AA (including TAA and AAA subtypes) were utilized.

Main Results:

  • Genetic evidence indicated that CD40 levels are inversely associated with the risk of AD (OR: 0.777) and AA (OR: 0.905).
  • These associations were consistent across thoracic AA (TAA) and abdominal AA (AAA) subtypes.
  • CD40L showed a trend towards increased risk for AD and AA, but did not reach statistical significance.

Conclusions:

  • This MR study provides strong evidence for a causal relationship between CD40 and reduced risks of both AD and AA.
  • The findings highlight CD40 as a potential therapeutic target for preventing aortic diseases.